Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cerebellar Modulation of Cognition in Psychosis

NCT: NCT06107764 · RECRUITING

NCT IDNCT06107764
StatusRECRUITING
Start Date2024-07-31
Completion2029-12
SponsorMclean Hospital (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn about cognition in psychotic disorders (schizophrenia, bipolar disorder, and schizoaffective disorder). The main question it aims to answer is: Can we use magnetic stimulation to change processing speed (how quickly people can solve challenging tasks). Participants will be asked to perform cognitive tasks (problem-solving) and undergo brain scans before and after transcranial magnetic stimulation (TMS). TMS is a way to non-invasively change brain activity. Forms of TMS are FDA-approved to treat depression and obsessive compulsive disorder. In this study, we will use a different form of TMS to temporarily change brain activity to observe how that changes speed in problem-solving.

Frequently Asked Questions

What is Cerebellar Modulation of Cognition in Psychosis?

Cerebellar Modulation of Cognition in Psychosis is a clinical trial registered under NCT06107764. Current status: RECRUITING.

What is the status of NCT06107764?

The current status of NCT06107764 (Cerebellar Modulation of Cognition in Psychosis) is: RECRUITING.

When did Cerebellar Modulation of Cognition in Psychosis start?

Cerebellar Modulation of Cognition in Psychosis started on 2024-07-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.